Strata Critical Medical, Inc. (SRTA)

NASDAQ: SRTA · Real-Time Price · USD

Compare

4.930

+0.120 (2.49%)

At close: Jan 2, 2026, 4:00 PM EST

4.820

-0.110 (-2.23%)

After-hours: Jan 2, 2026, 7:43 PM EST

Strata Critical Medical Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2021	2019 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Sep '21 Sep 30, 2021	2019 - 2020
Revenue	268.62	248.69	225.18	146.12	67.16	50.53	Upgrade
Revenue Growth (YoY)	70.11%	10.44%	54.11%	117.58%	32.92%	115.61%	Upgrade
Cost of Revenue	204.82	189.77	183.06	123.85	54.31	40.01	Upgrade
Gross Profit	63.8	58.92	42.12	22.28	12.85	10.52	Upgrade
Selling, General & Admin	85.59	82.42	82.18	67.23	42.96	32.66	Upgrade
Research & Development	3.51	3.18	4.63	5.55	2.16	1.68	Upgrade
Operating Expenses	89.1	85.61	86.8	72.77	45.11	34.34	Upgrade
Operating Income	-25.3	-26.69	-44.68	-50.5	-32.26	-23.82	Upgrade
Interest & Investment Income	5.19	7.21	8.44	3.43	0.74	0.46	Upgrade
Other Non Operating Income (Expenses)	-0.25	-0.85	2.13	24.23	-9.15	-20.06	Upgrade
EBT Excluding Unusual Items	-20.36	-20.33	-34.11	-22.84	-40.67	-43.42	Upgrade
Merger & Restructuring Charges	-2.64	-1.48	-	-3.03	-	-0.27	Upgrade
Gain (Loss) on Sale of Investments	-5.2	-	0.01	-2.16	-	-	Upgrade
Asset Writedown	-	-5.76	-20.75	-	-	-	Upgrade
Other Unusual Items	-	-	-2.68	-	-	-	Upgrade
Pretax Income	-33.51	-27.56	-57.54	-28.03	-40.67	-43.7	Upgrade
Income Tax Expense	-0.26	-0.26	-1.47	-0.77	-3.75	-3.64	Upgrade
Net Income	40.39	-27.31	-56.08	-27.26	-36.92	-40.05	Upgrade
Preferred Dividends & Other Adjustments	-	-	-	-	0.02	-	Upgrade
Net Income to Common	40.39	-27.31	-56.08	-27.26	-36.94	-40.05	Upgrade
Shares Outstanding (Basic)	81	77	74	71	54	43	Upgrade
Shares Outstanding (Diluted)	81	77	74	71	54	43	Upgrade
Shares Change (YoY)	5.22%	5.41%	3.21%	31.65%	26.18%	70.10%	Upgrade
EPS (Basic)	0.50	-0.35	-0.76	-0.38	-0.68	-0.93	Upgrade
EPS (Diluted)	0.50	-0.35	-0.76	-0.38	-0.68	-0.93	Upgrade
Free Cash Flow	-54.7	-33.39	-34.46	-37.86	-22.12	-15.91	Upgrade
Free Cash Flow Per Share	-0.68	-0.43	-0.47	-0.53	-0.41	-0.37	Upgrade
Gross Margin	23.75%	23.69%	18.71%	15.24%	19.14%	20.82%	Upgrade
Operating Margin	-9.42%	-10.73%	-19.84%	-34.56%	-48.04%	-47.15%	Upgrade
Profit Margin	15.04%	-10.98%	-24.90%	-18.66%	-55.00%	-79.27%	Upgrade
Free Cash Flow Margin	-20.36%	-13.43%	-15.30%	-25.91%	-32.93%	-31.49%	Upgrade
EBITDA	-17.63	-20.73	-37.57	-44.77	-31.09	-23.23	Upgrade
EBITDA Margin	-6.56%	-8.33%	-16.68%	-30.64%	-46.29%	-45.97%	Upgrade
D&A For EBITDA	7.67	5.96	7.11	5.73	1.17	0.6	Upgrade
EBIT	-25.3	-26.69	-44.68	-50.5	-32.26	-23.82	Upgrade
EBIT Margin	-9.42%	-10.73%	-19.84%	-34.56%	-48.04%	-47.15%	Upgrade
Advertising Expenses	-	2.71	4.06	4.54	-	1.89	Upgrade

Updated Nov 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q